These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 4476529

  • 1. [Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)].
    Iwai K, Honda H, Yamada S, Fukase M.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):501. PubMed ID: 4476529
    [No Abstract] [Full Text] [Related]

  • 2. [Proceedings: Clinical experience with administration of 2 alpha, 3 alpha- epithio-5 alpha-androstan-17 beta- yl, 1-methoxy-cyclopentyl ether (10364-S) in breast diseases].
    Izuo M, Okada T, Suemasu K, Fujimori M.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):509. PubMed ID: 4476537
    [No Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of mepitiostane on the growth of mammary tumor of a rat.
    Takatani O, Kumaoka S.
    Gan; 1977 Jun 20; 68(3):337-41. PubMed ID: 913955
    [Abstract] [Full Text] [Related]

  • 4. [Proceedings: Anti-estrogen action of 2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1-methoxy-cyclopentyl ether (10364-S)].
    Miyake T, Hori T, Ide M.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):511. PubMed ID: 4476538
    [No Abstract] [Full Text] [Related]

  • 5. Proceedings: 2 alpha, 3 alpha-epithio-5alpha-androstan-17beta-YL 1-methoxy-cyclophenyl ether (10364-S), a new orally active anabolic-androgenic steroid.
    Miyake T, Uchida K, Kakushi H, Nomura Y, Kadowaki M.
    Jpn J Pharmacol; 1974 Feb 20; 24(0):s:130. PubMed ID: 4545688
    [No Abstract] [Full Text] [Related]

  • 6. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether (10361-S), a new orally active anabolic-androgenic steroid.
    Miyake T, Uchida K, Kakushi H, Nomura Y, Kadowaki M.
    Jpn J Pharmacol; 1974 Aug 20; 24(4):551-8. PubMed ID: 4455965
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experiences with a new anabolic steroid: 2-formyl-17(alpha)methylandrosta-1,4-dien-11(alpha)17(beta)diol-3-one].
    Pardini C, Terreni F.
    Clin Ter; 1971 Aug 31; 58(4):343-50. PubMed ID: 5158278
    [No Abstract] [Full Text] [Related]

  • 8. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
    Cancer; 1978 Feb 31; 41(2):758-60. PubMed ID: 343913
    [Abstract] [Full Text] [Related]

  • 9. [Human pharmacological study of quinbolone. Clinical and laboratory investigations of the effects of anabolic treatment in aged women].
    Mezzena R, Foresti M, Trisotto M, Bruni G.
    G Gerontol; 1972 Apr 31; 20(4):361-78. PubMed ID: 5042390
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical results of a long-acting anabolic steroid, oxynosterone cypionate (TBS) in pediatrics].
    Matsumura T, Uehara Y, Ebina T.
    Nihon Rinsho; 1968 Dec 31; 26(12):3522-7. PubMed ID: 5753032
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of aplastic anemia with mepitiostane (author's transl)].
    Toyama K, Kaneko J, Suzuki H, Negishi M, Nakada I, Tobita K, Katayama T.
    Rinsho Ketsueki; 1979 Feb 31; 20(2):121-7. PubMed ID: 439410
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic effects of furazabol, (17-beta-hydroxy-17-alpha-methyl-5-alpha-androstane [2, 3-c] furazan, on experimental atherosclerosis in rabbits].
    Onodera T, Kasahara A, Ishihara M, Ogawa H, Oshima Y.
    Nihon Yakurigaku Zasshi; 1970 Jul 20; 66(4):458-69. PubMed ID: 5531414
    [No Abstract] [Full Text] [Related]

  • 13. 2 ,3 - Epithio-5 -androstan-17 -ol in the treatment of advanced breast cancer.
    Fujimori M.
    Cancer; 1973 Apr 20; 31(4):789-92. PubMed ID: 4574661
    [No Abstract] [Full Text] [Related]

  • 14. [Studies of the effect of a new anabolic agent in burned patients].
    Roman Calderon J.
    Prensa Med Mex; 1968 Apr 20; 33(1):51-3. PubMed ID: 5760271
    [No Abstract] [Full Text] [Related]

  • 15. Effects of 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (epitiostanol) on hypothalamo-pituitary-gonadal axis in humans.
    Kurachi K, Aono T, Tomoyama J, Matsumoto K, Nakasima A.
    Acta Obstet Gynaecol Jpn; 1975 Jan 20; 22(1):42-8. PubMed ID: 1224948
    [No Abstract] [Full Text] [Related]

  • 16. 2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
    Miyake T, Hori T, Kato G, Ide M, Uchida N, Yamaguchi K.
    Steroids; 1974 Jun 20; 23(6):929-37. PubMed ID: 4836439
    [No Abstract] [Full Text] [Related]

  • 17. [Evaluation of Parenabol--a long-term anabolizing drug].
    Stopczyk K.
    Wiad Lek; 1971 Jul 01; 24(3):277-82. PubMed ID: 5548725
    [No Abstract] [Full Text] [Related]

  • 18. [Factors stimulating liver regeneration; role of anabolic steroids in reactive regeneration in chronic liver diseases].
    Nicolaescu T, Bordeianu A, Bittman E, Gabrielescu E, Stoiculescu P, Drăgulescu N.
    Rev Roum Physiol; 1969 Jul 01; 6(2):119-26. PubMed ID: 5821595
    [No Abstract] [Full Text] [Related]

  • 19. Androgen therapy.
    Longson D.
    Practitioner; 1972 Mar 01; 208(245):338-48. PubMed ID: 4557109
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention and treatment of dysproteinemic syndromes in hospitalized aged persons].
    Rubegni M, Provvedi D, Bandinelli C, De Mauro G, Bellini PG.
    G Gerontol; 1972 Jan 01; 20(1):50-61. PubMed ID: 5023588
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.